ADARx Pharmaceuticals Inc. logo

ADARx Pharmaceuticals Inc.

ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics.  ADARx has developed proprietary RNA targeting platforms and oligonucleotide delivery technologies for inhibition, degradation, and ed...

84

ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics.  ADARx has developed proprietary RNA targeting platforms and oligonucleotide delivery technologies for inhibition, degradation, and editing disease-causing mRNA. ADARx has a growing pipeline of RNA targeting therapeutics for treating diseases across a range of therapeutic areas including genetic, cardiometabolic, complement-mediated diseases and central nervous system diseases.  We are well-financed by a syndicate of renowned VC firms.

ADARx currently has multiple active programs in development. Our lead candidate is at the clinical stage.

Benefits & Perks

Equity-Based Compensation
Performance-Based Bonuses
401(k) With Company Match
Medical
Dental
Vision
Flexible Spending Account
Life Insurance
Employee Assistance Program
Employee Discounts
Gym Membership
Paid Vacation
Paid Holidays
Paid Sick
Jury Duty
Bereavement

Frequently Asked Questions

How many employees does ADARx Pharmaceuticals Inc. have?

ADARx Pharmaceuticals Inc. has around 84 employees. As a Biotechnology Research company, they are actively growing their team with 0 open positions.

Why should I join ADARx Pharmaceuticals Inc.?

The company offers great benefits including Equity-Based Compensation, Performance-Based Bonuses, 401(k) With Company Match.

What does ADARx Pharmaceuticals Inc. do?

ADARx Pharmaceuticals Inc. is a Biotechnology Research company. ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics. ADARx has developed proprietary RN...